News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
438,678 Results
Type
Article (27330)
Company Profile (325)
Press Release (411023)
Section
Business (125754)
Career Advice (299)
Deals (20983)
Drug Delivery (51)
Drug Development (63962)
Employer Resources (44)
FDA (8905)
Job Trends (7278)
News (217641)
Policy (17003)
Tag
Academia (1313)
Alliances (35138)
Alzheimer's disease (893)
Approvals (8877)
Artificial intelligence (94)
Bankruptcy (157)
Best Places to Work (6156)
Biotechnology (264)
Breast cancer (152)
Cancer (1177)
Cardiovascular disease (89)
Career advice (258)
CAR-T (89)
Cell therapy (255)
Clinical research (50930)
Collaboration (404)
Compensation (183)
COVID-19 (2139)
C-suite (100)
Cystic fibrosis (76)
Data (1225)
Diabetes (110)
Diagnostics (2823)
Earnings (39995)
Events (77888)
Executive appointments (317)
FDA (9410)
Funding (379)
Gene therapy (183)
GLP-1 (378)
Government (1969)
Healthcare (9065)
Infectious disease (2201)
Inflammatory bowel disease (106)
IPO (9582)
Job creations (1545)
Job search strategy (238)
Layoffs (229)
Legal (3342)
Lung cancer (169)
Lymphoma (94)
Manufacturing (138)
Medical device (4632)
Medtech (4633)
Mergers & acquisitions (11612)
Metabolic disorders (325)
Neuroscience (1175)
NextGen Class of 2024 (2849)
Non-profit (1288)
Northern California (1346)
Obesity (179)
Opinion (167)
Parkinson's disease (90)
Patents (77)
People (44229)
Phase I (17029)
Phase II (23304)
Phase III (15665)
Pipeline (455)
Postmarket research (1499)
Preclinical (7036)
Radiopharmaceuticals (213)
Rare diseases (236)
Real estate (2780)
Regulatory (12691)
Research institute (1269)
Southern California (1208)
Startups (2983)
United States (11284)
Vaccines (404)
Weight loss (105)
Date
Today (4)
Last 7 days (302)
Last 30 days (1888)
Last 365 days (25916)
2024 (25837)
2023 (27431)
2022 (35027)
2021 (38117)
2020 (33282)
2019 (21717)
2018 (16096)
2017 (22103)
2016 (22759)
2015 (28107)
2014 (21392)
2013 (17607)
2012 (18078)
2011 (17822)
2010 (16311)
Location
Africa (365)
Arizona (96)
Asia (27427)
Australia (4433)
California (3086)
Canada (1073)
China (236)
Colorado (120)
Connecticut (158)
Delaware (77)
Europe (62901)
Florida (365)
Georgia (96)
Illinois (270)
Indiana (99)
Maryland (424)
Massachusetts (2412)
Michigan (85)
Minnesota (138)
New Jersey (879)
New York (883)
North Carolina (514)
Northern California (1346)
Ohio (97)
Pennsylvania (604)
South America (645)
Southern California (1208)
Texas (415)
Washington State (314)
438,678 Results for "amarna therapeutics b v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amarna Therapeutics Partners with NorthX Biologics to Advance Nimvec™ AM510 Gene Therapy Development
December 4, 2024
·
5 min read
Press Releases
Phenocell and Amarna Therapeutics Awarded Eurostars Grant to Assess a Gene Therapy for Dry AMD using a novel 3-dimensional iPSC-derived Retinal Model of the Disease
December 11, 2024
·
4 min read
Business
Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officer
Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases, including Type 1 Diabetes Mellitus, announces the appointment of Aurelia Caparrós as the Company’s new Chief Business Officer, effective 1st of April 2024.
April 19, 2024
·
3 min read
Business
Amarna Therapeutics announces formation of Scientific Advisory Board to support advancement of groundbreaking Nimvec™ AM510 gene therapy against Type 1 Diabetes
Amarna Therapeutics, a privately-held biotechnology company focused on developing transformative gene therapies for a range of rare and prevalent genetic diseases, including Type 1 Diabetes Mellitus, is pleased to announce the formation of its new Scientific Advisory Board. The newly established SAB consists of seven distinguished international scientific opinion leaders.
June 17, 2024
·
7 min read
Press Releases
Amarna Therapeutics Receives Constructive Feedback from FDA INTERACT Meeting for AM510 Gene Therapy Development Targeting Type 1 Diabetes
August 27, 2024
·
3 min read
Press Releases
MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio
December 17, 2024
·
5 min read
Press Releases
Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024
October 28, 2024
·
9 min read
Deals
Clade Therapeutics Announces the Acquisition of Gadeta B.V.
Clade Therapeutics today announced that it has completed the acquisition of Gadeta B.V.
October 2, 2023
·
4 min read
Press Releases
Vivoryon Therapeutics N.V. Reports Q3 2024 Results and Highlights Progress on Varoglutamstat in Kidney Disease
December 10, 2024
·
13 min read
Pharm Country
Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership
Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic Pharma, Inc. on March 4, 2024, following the change in ownership of the company from SEVER Life Sciences, B.V. to Nordic Group, B.V., a subsidiary of SEVER Life Sciences B.V., which occurred on June 1, 2023.
March 4, 2024
·
3 min read
1 of 43,868
Next
